Viewing Study NCT04516967


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
Study NCT ID: NCT04516967
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2020-08-14
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
Sponsor: Sobi, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-03-05
Start Date Type: ACTUAL
Primary Completion Date: 2023-11-08
Primary Completion Date Type: ACTUAL
Completion Date: 2025-10-28
Completion Date Type: ESTIMATED
First Submit Date: 2020-08-14
First Submit QC Date: None
Study First Post Date: 2020-08-18
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-11-07
Results First Submit QC Date: None
Results First Post Date: 2025-01-17
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-17
Last Update Post Date: 2025-10-01
Last Update Post Date Type: ESTIMATED